Literature DB >> 8468414

The cutaneous histopathology of chemotherapeutic reactions.

J E Fitzpatrick1.   

Abstract

The histological diagnosis of chemotherapy-induced cutaneous reactions is a difficult problem for the dermatopathologist. The initial effort should be directed towards obtaining as much clinical history as possible since the provided information is often incomplete and clinical correlation is usually required. The biopsy should be examined in a systematic fashion to assess the presence of damage to specific cutaneous structures. A recommended approach is to initially examine the epidermis and then proceed to hair follicles, eccrine sweat glands, vessels and dermis. The degree and pattern of damage will usually indicate whether or not a cytotoxic reaction is present. The intensity, pattern, and components of the inflammatory response should be assessed since they provide clues to whether a hypersensitivity reaction or immunomodulating chemotherapeutic reaction is present. In addition to the possibility of a chemotherapeutic reaction, the dermatopathologist must also consider the possibility of an infection since the host is usually immunocompromised and must also exclude the presence of a residual malignancy. After examination of the biopsy specimen and determination of the pathologic process or precesses, the observed findings should be correlated with the clinical history before rendering an interpretation.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8468414     DOI: 10.1111/j.1600-0560.1993.tb01242.x

Source DB:  PubMed          Journal:  J Cutan Pathol        ISSN: 0303-6987            Impact factor:   1.587


  10 in total

Review 1.  My approach to superficial inflammatory dermatoses.

Authors:  K O Alsaad; D Ghazarian
Journal:  J Clin Pathol       Date:  2005-12       Impact factor: 3.411

2.  Autologous GVHD?

Authors:  F Otegbeye; R P Gale; H M Lazarus
Journal:  Bone Marrow Transplant       Date:  2014-08-04       Impact factor: 5.483

3.  Keratinocyte dysplasia in hematopoietic stem cell transplantation recipients in the day-28-to-84 posttransplantation period.

Authors:  Ning Li; Katherine A Guthrie; Barry E Storer; Paul J Martin; George E Sale; Zsolt B Argenyi; David Myerson
Journal:  Biol Blood Marrow Transplant       Date:  2012-02-10       Impact factor: 5.742

Review 4.  Prevention strategies for chemotherapy-induced hand-foot syndrome: a systematic review and meta-analysis of prospective randomised trials.

Authors:  Lígia Traldi Macedo; Joao Paulo Nogueira Lima; Lucas Vieira dos Santos; Andre Deeke Sasse
Journal:  Support Care Cancer       Date:  2014-01-26       Impact factor: 3.603

5.  Docetaxel-induced skin toxicities in breast cancer patients subsequent to paclitaxel shortage: a case series and literature review.

Authors:  Ming J Poi; Michael Berger; Maryam Lustberg; Rachel Layman; Charles L Shapiro; Bhuvaneswari Ramaswamy; Ewa Mrozek; Erin Olson; Robert Wesolowski
Journal:  Support Care Cancer       Date:  2013-05-19       Impact factor: 3.603

6.  Chemotherapy-induced dermatological toxicity: frequencies and impact on quality of life in women's cancers. Results of a prospective study.

Authors:  Mark Hackbarth; Norbert Haas; Christina Fotopoulou; Werner Lichtenegger; Jalid Sehouli
Journal:  Support Care Cancer       Date:  2007-08-07       Impact factor: 3.603

7.  CPX-351 (Vyxeos®) can cause severe rash in acute myeloid leukemia-A case report.

Authors:  Ruth M Urbantat; Valentin Popper; Elisabeth Menschel; Michael Pfeilstöcker; Ernst Forjan; Alexander Nader; Catherine R Sieghart; Felix Keil; Elisabeth Koller
Journal:  Clin Case Rep       Date:  2021-02-12

8.  Compliance and effective management of the hand-foot syndrome in colon cancer patients receiving capecitabine as adjuvant chemotherapy.

Authors:  Hyun-Sook Son; Woo Yong Lee; Won-Suk Lee; Seong Hyeon Yun; Ho-Kyung Chun
Journal:  Yonsei Med J       Date:  2009-12-18       Impact factor: 2.759

9.  Pathogenesis of Hand-Foot Syndrome induced by PEG-modified liposomal Doxorubicin.

Authors:  Noriyuki Yokomichi; Teruaki Nagasawa; Ariella Coler-Reilly; Hiroyuki Suzuki; Yoshiki Kubota; Ryosuke Yoshioka; Akiko Tozawa; Nao Suzuki; Yoko Yamaguchi
Journal:  Hum Cell       Date:  2013-02-06       Impact factor: 4.174

10.  Nasal involvement in hand and foot syndrome.

Authors:  Anil Mishra; Prashanna R Shrestha; R V Ramanna Rao; Ajay Kumar
Journal:  Indian J Dermatol       Date:  2013-03       Impact factor: 1.494

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.